1 / 2

Ajanta Pharma Ltd - LargecapIndia.com

Large CapIndia u2013 Best Share / Stock Market tips, Intraday trading online.<br>https://www.largecapindia.com/

largecapindia
Download Presentation

Ajanta Pharma Ltd - LargecapIndia.com

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ajanta Pharma Ltd Ajanta Pharma Limited (APL) is a multinational company based in India engaged in development, manufacturing, and marketing of pharmaceutical formulations. The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia. The company’s Chairman is Mr. Mannalal Agrawal and Mr. Yogesh Agrawal is the Managing Director Ajanta Pharma Ltd was incorporated in 1979, it is a Mid Cap company having a market capital of Rs 12624.52 Crore. The company runs three divisions — prescription drugs, OTC and institutional sales. They cater to therapeutic areas like cardiology, ophthalmology and dermatology. They manufacture various dosage forms such as tablets, capsules, injections, ointments and powders. The company’s research and development division conduct activities in three aspects namely new drug delivery system (NDDS), formulation and development and herbal / nutraceutical. Ajanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 1762.69 Crore to Sales Value (96.29 % of Total Sales), Export Incentives which contributed Rs 66.17 Crore to Sales Value (3.61 % of Total Sales) and Other Operating Revenue which contributed Rs 1.59 Crore to Sales Value (0.08 % of Total Sales)for the year ending 31-Mar-2018. For the quarter ended 31-12-2019, the company has reported a Consolidated sale of Rs 651.21 Crore, up 1.31 % from last quarter Sales of Rs 642.76 Crore and up 34.24 % from last year same quarter Sales of Rs 485.11 Crore Company has reported net profit after tax of Rs 107.55 Crore in latest quarter. As on 31-12-2019, the company has a total of 87,261,270 shares outstanding.

  2. If you find any mistake please contact the support@largecapindia.co.in. This article is general in nature. It does not constitute a recommendation to buy and sell any stock, and does not take account of your objectives, or your financial situation. Largecapindia has no position in the stocks mentioned. Largecapindia aim to bring you long term focused research analysis driven by fundamental thanks you. For More Info : https://www.largecapindia.com

More Related